[Cystatin C as a biological marker for diagnosis of diabetic nephropathies].

Suppr

超能文献

作者信息

Kuboki Koji, Kojima Masato, Yoshino Gen

机构信息

Division of Diabetes, Metabolism and Endocrinology, Department of Medicine, Toho University School of Medicine.

出版信息

Nihon Rinsho. 2005 Jun;63 Suppl 6:367-72.

PMID:15999736

Abstract

摘要

相似文献

[Cystatin C as a biological marker for diagnosis of diabetic nephropathies].

Nihon Rinsho. 2005 Jun;63 Suppl 6:367-72.

[Cystatin C].

Nihon Rinsho. 2002 Aug;60 Suppl 8:515-9.

[Cystatin C as a marker of glomerular filtration rate].

Postepy Hig Med Dosw. 2001;55(5):687-98.

Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis.

Am J Kidney Dis. 2002 Aug;40(2):221-6. doi: 10.1053/ajkd.2002.34487.

Accounting for body composition does not improve cystatin C estimation of GFR in diabetic subjects with CKD.

Am J Kidney Dis. 2007 Apr;49(4):560; author reply 561. doi: 10.1053/j.ajkd.2007.01.024.

Cystatin C does not detect acute changes in glomerular filtration rate in early diabetic nephropathy.

Ren Fail. 2008;30(1):21-9. doi: 10.1080/08860220701741916.

Increased serum cystatin C is associated with increased mortality in elderly men.

Scand J Clin Lab Invest. 2005;65(4):301-5. doi: 10.1080/00365510510013839.

Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy.

J Intern Med. 2004 Dec;256(6):510-8. doi: 10.1111/j.1365-2796.2004.01414.x.

Serum cystatin C: a replacement for creatinine as a biochemical marker of GFR.

Kidney Int Suppl. 1994 Nov;47:S20-1.

Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes.

Am J Kidney Dis. 2001 Aug;38(2):310-6. doi: 10.1053/ajkd.2001.26096.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Cystatin C as a biological marker for diagnosis of diabetic nephropathies].

Nihon Rinsho. 2005 Jun;63 Suppl 6:367-72.

[Cystatin C].

Nihon Rinsho. 2002 Aug;60 Suppl 8:515-9.

[Cystatin C as a marker of glomerular filtration rate].

Postepy Hig Med Dosw. 2001;55(5):687-98.

Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis.

Am J Kidney Dis. 2002 Aug;40(2):221-6. doi: 10.1053/ajkd.2002.34487.

Accounting for body composition does not improve cystatin C estimation of GFR in diabetic subjects with CKD.

Am J Kidney Dis. 2007 Apr;49(4):560; author reply 561. doi: 10.1053/j.ajkd.2007.01.024.

Cystatin C does not detect acute changes in glomerular filtration rate in early diabetic nephropathy.

Ren Fail. 2008;30(1):21-9. doi: 10.1080/08860220701741916.

Increased serum cystatin C is associated with increased mortality in elderly men.

Scand J Clin Lab Invest. 2005;65(4):301-5. doi: 10.1080/00365510510013839.

Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy.

J Intern Med. 2004 Dec;256(6):510-8. doi: 10.1111/j.1365-2796.2004.01414.x.

Serum cystatin C: a replacement for creatinine as a biochemical marker of GFR.

Kidney Int Suppl. 1994 Nov;47:S20-1.

Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes.

Am J Kidney Dis. 2001 Aug;38(2):310-6. doi: 10.1053/ajkd.2001.26096.